ARC
ROIV icon

Advisor Resource Council’s Roivant Sciences ROIV Stock Holding History

Advisor Resource Council’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
+6,929
New +$205K 0.07% 231

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Advisor Resource Council's ROIV Position: Q2 2026 in Review

Advisor Resource Council opened a new position in Roivant Sciences (ROIV) in Q2 2026: 6,929 shares worth $245K. The stake represents 0.07% of the portfolio and ranks #231 among its holdings.

498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Advisor Resource Council held 6,929 shares of Roivant Sciences worth $245K as of Q2 2026.
  • Roivant Sciences was a new Advisor Resource Council position in Q2 2026.
  • Roivant Sciences made up 0.07% of Advisor Resource Council's portfolio in Q2 2026, its #231 holding.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Advisor Resource Council's 13F filing for Q2 2026, filed 28 Jul 2026.